Bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor
AssigneePeter W. Zandstra
InventorsStephen Dang, Peter W. Zandstra
Life of this patent
Estimating the term…
Loading patent…
AssigneePeter W. Zandstra
InventorsStephen Dang, Peter W. Zandstra
Estimating the term…
The present inventors identified aggregation of embryonic stem cells and embryoid bodies (EBs) as the cause of the difficulty in generating large numbers of the embryonic stem cells (ES) cell-derived tissues. To counter this, the invention provides a novel bioprocess where aggregation of spheroid forming cells, such as embryonic stem cells and spheroids, such as EBs is controlled, such as by encapsulation of within a matrix. As a result, EBs can be generated with high efficiency and cultured in high cell density, well-mixed systems. Well-mixed conditions facilitate measurement and control of the bulk media conditions and allow for the use of scalable bioreactor systems for clinical production of tissue. Therefore, the invention enables generation of ES cell-derived tissue on a clinical scale. The invention is also applicable to any spheroid-forming cells and other types of pluripotent cells.
A bioprocess for controlling aggregation of embryoid bodies during differentiation, comprising:
Dependencies are inferred from the claim text.